首页 | 本学科首页   官方微博 | 高级检索  
检索        

NP与NO方案治疗老年晚期非小细胞肺癌的对比观察
引用本文:谢彦,陈冬波,王保庆.NP与NO方案治疗老年晚期非小细胞肺癌的对比观察[J].肿瘤基础与临床,2011,24(5):393-394.
作者姓名:谢彦  陈冬波  王保庆
作者单位:徐州医学院第二附属医院肿瘤内科,江苏徐州,221006
摘    要:目的 比较长春瑞滨联合顺铂(NP)与长春瑞滨联合奥沙利铂(N0)方案治疗老年晚期非小细胞肺癌( NSCLC)的临床疗效和毒副反应.方法56例无法手术或术后复发转移的老年晚期NSCLC随机分为两组,分别给予NP和NO方案化疗,治疗2个周期后分别评价临床疗效和毒副反应.结果NP方案组总有效率为46.2%,NO方案组为50....

关 键 词:老年患者  晚期非小细胞肺癌  长春瑞滨  顺铂  奥沙利铂

Comparative Observation of NP and NO Regimens in the Treatment of the Elderly Patients with Advanced Non-Small Cell Lung Cancer
Xie Yah,Chen Dongbo,Wang Baoqing.Comparative Observation of NP and NO Regimens in the Treatment of the Elderly Patients with Advanced Non-Small Cell Lung Cancer[J].journal of basic and clinical oncology,2011,24(5):393-394.
Authors:Xie Yah  Chen Dongbo  Wang Baoqing
Institution:(Department of Oncology,the Second Affiliated Hospital of Xuzhou Medical College,Xuzhou 221006,China)
Abstract:Objective To compare the efficacy and toxicities of vinorelbine plus cisplatin(NP) and vinorelbine plus oxaliplatin(NO) regimens in the treatment of the elderly patients with advanced non-small cell lung cancer(NSCLC).Methods The 56 inoperable or recurrent patients with NSCLC were randomized into two groups,and received NP and NO regimens chemotherapy respectively.The efficacy and toxicities were respectively evaluated after two cycles of chemotherapy.Results The total effective rate in the NP group was 46.2%,and was 50.0% in the NO group(P>0.05).Myelosuppression with grade Ⅲ-Ⅳ: the 11 patients(42.3%) in the NP group and the 8 patients(26.7%) in the NO group;gastrointestinal reaction with grade Ⅲ-Ⅳ: the 6 patients(23.1%) in the NP group and the 2 patients(6.7%) in the NO group;neurotoxicity: the 2 patients(7.7%) in the NP group and the 28 patients(93.3%) in the NO group(P<0.05).Conclusion NP and NO regimens are effective for the elderly patients with advanced NSCLC;and the toxicities of NO regimen is lighter,it may be safer for the elderly patients.
Keywords:elderly patient  non-small cell lung cancer  vinorelbine  cisplatin  oxaliplatin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号